Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Feb 05, 2020 $71.35 $72.96 $70.82 $72.17 1 000 097
Feb 04, 2020 $67.01 $71.38 $66.37 $71.27 1 023 750
Feb 03, 2020 $62.81 $67.00 $62.81 $65.82 767 053
Jan 31, 2020 $65.10 $66.86 $61.80 $65.26 1 382 765
Jan 30, 2020 $68.09 $68.93 $66.80 $67.98 704 221
Jan 29, 2020 $72.62 $72.62 $68.32 $68.44 736 402
Jan 28, 2020 $70.80 $73.89 $70.32 $70.45 673 541
Jan 27, 2020 $71.15 $73.55 $69.37 $70.15 1 218 504
Jan 24, 2020 $79.64 $79.96 $72.90 $73.13 1 548 375
Jan 23, 2020 $80.19 $81.49 $78.11 $79.74 722 287
Jan 22, 2020 $82.00 $82.60 $80.35 $80.83 921 614
Jan 21, 2020 $83.73 $83.77 $81.25 $82.07 1 311 584
Jan 17, 2020 $87.17 $87.54 $83.53 $83.76 820 411
Jan 16, 2020 $86.84 $87.50 $82.51 $87.20 1 412 640
Jan 15, 2020 $84.13 $86.45 $83.63 $85.68 1 196 636
Jan 14, 2020 $81.31 $84.42 $79.60 $84.31 1 047 419
Jan 13, 2020 $83.58 $83.58 $78.50 $81.23 1 310 037
Jan 10, 2020 $84.24 $86.06 $83.32 $83.40 1 111 150
Jan 09, 2020 $82.01 $84.25 $82.01 $83.81 1 009 139
Jan 08, 2020 $79.33 $82.84 $79.09 $81.93 1 140 088
Jan 07, 2020 $79.13 $79.99 $78.02 $79.36 838 261
Jan 06, 2020 $77.20 $79.78 $76.71 $78.94 724 038
Jan 03, 2020 $77.47 $79.97 $76.08 $78.59 568 454
Jan 02, 2020 $79.78 $79.78 $77.75 $78.57 673 126
Dec 31, 2019 $78.95 $80.64 $78.88 $79.49 448 746
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT